Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005341820 | SCV006004714 | uncertain significance | not specified | 2024-12-21 | criteria provided, single submitter | clinical testing | The c.151T>C (p.Y51H) alteration is located in exon 2 (coding exon 1) of the FBXO39 gene. This alteration results from a T to C substitution at nucleotide position 151, causing the tyrosine (Y) at amino acid position 51 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |